XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities    
Net Income (loss) $ 1,766 $ 1,447
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization expense excluding depreciation and amortization of assets under operating leases 276 252
Depreciation and amortization expense of assets under operating leases 140 155
(Gain) loss on disposal of assets, net 21 22
Undistributed (income) loss of unconsolidated subsidiaries (125) (36)
Other non-cash items, net 136 130
Changes in operating assets and liabilities:    
Provisions 618 (21)
Deferred income taxes (319) 83
Trade and financing receivables related to sales, net (1,602) (1,279)
Inventories, net (1,443) (1,121)
Trade payables (101) (120)
Other assets and liabilities 25 (398)
Net cash provided (used) by operating activities (608) (886)
Cash Flows from Investing Activities    
Additions to retail receivables (5,689) (4,179)
Collections of retail receivables 4,308 3,342
Proceeds from the sale of assets, excluding assets under operating leases 1 25
Expenditures for property, plant and equipment and intangible assets, excluding assets under operating leases (401) (245)
Expenditures for assets under operating leases (384) (368)
Other 123 (165)
Net cash provided (used) by investing activities (2,042) (1,590)
Cash Flows from Financing Activities    
Proceeds from long-term debt 7,510 7,727
Payments of long-term debt (6,478) (6,733)
Net increase in other financial liabilities 930 340
Dividends paid (531) (416)
Purchase of treasury stock and other (224) (116)
Net cash provided (used) by financing activities 1,207 802
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash (1) (357)
Net increase (decrease) in cash, cash equivalents and restricted cash (1,444) (2,031)
Cash, cash equivalents and restricted cash, beginning of year 5,129 5,845
Cash, cash equivalents and restricted cash, end of period $ 3,685 $ 3,814